Clinical implications of next-generation sequencing for cancer medicine

Por Shuen, A., Foulkes, W.D.
Publicado em 2010

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

Por Osher, D J, De Leeneer, K, Michils, G, Hamel, N, Tomiak, E, Poppe, B, Leunen, K, Legius, E, Shuen, A, Smith, E, Arseneau, J, Tonin, P, Matthijs, G, Claes, K, Tischkowitz, M D, Foulkes, W D
Publicado em 2012